InvestorsHub Logo
Followers 30
Posts 2216
Boards Moderated 0
Alias Born 03/21/2014

Re: jondoeuk post# 523

Friday, 10/11/2024 8:48:20 AM

Friday, October 11, 2024 8:48:20 AM

Post# of 530
There is a pretty simple math equation here - would an otherwise incurable patient rather live with their debilitating illness (for a short time before death or with periods of excruciating pain), or accept a less than or about 10% chance of developing a cancer that can be cured?

Bluebird has no patent or I.P. issues. That's Crisper and Vertex, not Lyfgenia. Again, not Bluebird. Those that have been paying attention and following this company are well aware of the cash issues and impending R/S. This is nothing but fear-mongering.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLUE News